Article citationsMore>>

Ortega-González, C., Luna, S., Hernández, L., Crespo, G., Aguayo, P., Arteaga-Troncoso, G., et al. (2005) Responses of Serum Androgen and Insulin Resistance to Metformin and Pioglitazone in Obese, Insulin-Resistant Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism, 90, 1360-1365.
https://doi.org/10.1210/jc.2004-1965

has been cited by the following article:

• TITLE: Study of Prevalence of Menstrual Disorders in Cases of Insulin Resistance in Patients with Polycystic Ovary Syndrome

  AUTHORS: Mais Hayek

  KEYWORDS: Polycystic Ovary Syndrome, Menstrual Disorders, Insulin Resistance

  JOURNAL NAME: Open Access Library Journal, Vol.11 No.11, November 28, 2024

  ABSTRACT: Background: Polycystic ovary syndrome PCOs is a common hormonal disorder that affects women of childbearing age. Insulin resistance plays an important role in the pathogenesis of PCOs, especially menstrual disorders and infertility. In this study, we will try to find the importance of improving insulin resistance in achieving regular menstrual periods. Objective: Studying the correlation of menstrual disorders in polycystic ovary syndrome patients and insulin-resistant conditions to decide the best and the most effective treatment. Methods: This study included patients with polycystic ovary syndrome and insulin resistance who had visited obstetrics and gynecology clinic in Tishreen University Hospital, Lattakia. Insulin resistance was calculated for all patients at the first visit. In addition to clinical assessment with ultrasound examination. Results: This study included 65 women with insulin resistance and diagnosed with polycystic ovary syndrome. The age of the participants ranged between 22 - 40 years, with an average age of 28.3 ± 3.63 years. All of them suffered from menstrual disorders, bradymenorrhea accounted for the largest percentage of the sample, with more than 66% of cases. Conclusion: Our study found a significant role of reducing insulin resistance in improving ovulation and menstrual disorders in patients with Polycystic Ovary Syndrome (PCOs).